Yen‐Yang Chen

Updated results of a phase IIa study to evaluate the clinical efficacy and safety of erdafitinib in Asian advanced cholangiocarcinoma (CCA) patients with FGFR alterations.

Joon Oh Park, Yin‐Hsun Feng, Yen‐Yang Chen et al. · Journal of Clinical Oncology · 2019 · 78 citations

Medicine, Oncology, Pharmacology +14

Pembrolizumab versus paclitaxel for previously treated advanced gastric or gastroesophageal junction cancer (KEYNOTE‐063): A randomized, open‐label, phase 3 trial in Asian patients

Hyun Cheol Chung, Yoon‐Koo Kang, Zhendong Chen et al. · Cancer · 2021 · 70 citations · Full text

Medicine, Oncology, Pharmacology +14

A phase II trial of regorafenib in patients with metastatic and/or a unresectable gastrointestinal stromal tumor harboring secondary mutations of exon 17

Chun‐Nan Yeh, Ming‐Huang Chen, Yen‐Yang Chen et al. · Oncotarget · 2017 · 60 citations · Full text

Medicine, Hematology, Oncology +12

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab

Jing‐Houng Wang, Yen‐Yang Chen, Yen‐Yang Chen et al. · Cancers · 2022 · 49 citations · Full text

Medicine, Oncology, Pharmacology +14

Sunitinib for Taiwanese patients with gastrointestinal stromal tumor after imatinib treatment failure or intolerance

Yen‐Yang Chen · World Journal of Gastroenterology · 2011 · 48 citations · Full text

Medicine, Oncology, Pharmacotherapy +14